Stefan Luzi
Direktor/Vorstandsmitglied bei Amphista Therapeutics Ltd.
Ursprung des Netzwerks ersten Grades von Stefan Luzi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
Gilde Healthcare Partners BV
 Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.
21
| Subsidiary | Investment Managers | 21 |
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson.
8
| Holding Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stefan Luzi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotie Therapies AG
 Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding company that focuses on developing drugs for the treatment of psychiatry and neurology diseases. The company is based in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Gilde Investment Management BV
 Gilde Investment Management BV Investment ManagersFinance Gilde Investment Management BV is an Independent Private Equity firm founded in 1982. Gilde Investment Management BV is headquartered in Utrecht. | Investment Managers | Investment Committee Member Private Equity Investor | |
| GENMAB A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Parcom Capital Management BV
 Parcom Capital Management BV Investment ManagersFinance Parcom Capital Management BV is an independent private equity firm founded in 1982. Parcom Capital Management BV is headquartered in Amsterdam. | Investment Managers | Private Equity Analyst | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
| University of Cambridge | College/University | Masters Business Admin Doctorate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Synexa Life Sciences BV
 Synexa Life Sciences BV BiotechnologyHealth Technology Synexa Life Sciences BV is a Dutch company that specializes in Biomarker and Bioanalysis Research Services. The company is based in Leiden, Netherlands. The company has expertise in designing and delivering biomarker strategies for biopharma clients. and has subsidiaries in Finland. The company was founded in 2003 by Justin Devine, Patrick Bouic, Paul O'Riordan. The CEO is Emile Lens. | Biotechnology | Director/Board Member Director/Board Member | |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Director/Board Member | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Tridek-One Therapeutics SAS
 Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Leiden | College/University | Graduate Degree Undergraduate Degree | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder Chief Operating Officer | |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Erasmus University Rotterdam | College/University | Graduate Degree Graduate Degree | |
Gilde Healthcare Holding BV
 Gilde Healthcare Holding BV Financial ConglomeratesFinance Gilde Healthcare Holding BV is an investment holding Dutch company. The private company is based in Utrecht, NL. and has subsidiaries in Australia, Netherlands, United States and Germany. The CEOs of the company are Edwin William de Graaf, Marc Olivier Perret. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Mosaic Biomedicals SL
 Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain. | Hospital/Nursing Management | Director/Board Member | |
Leids Universitair Medisch Centrum
 Leids Universitair Medisch Centrum Hospital/Nursing ManagementHealth Services Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| University of Amsterdam | College/University | Doctorate Degree | |
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member | |
| Versant Ventures (Switzerland) GmbH | Investment Managers | Private Equity Investor | |
| All India Institute of Medical Sciences | College/University | Doctorate Degree | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
The Cancer Prevention & Research Institute of Texas
 The Cancer Prevention & Research Institute of Texas BiotechnologyHealth Technology Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX. | Biotechnology | Corporate Officer/Principal | |
Avon Foundation For Women
 Avon Foundation For Women Investment Trusts/Mutual FundsMiscellaneous Avon Foundation For Women provides granting services. The non-profit company is based in New York, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Institut Gustave Roussy EURL
 Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 14 |
| Niederlande | 12 |
| Vereinigtes Königreich | 7 |
| Schweiz | 5 |
| Frankreich | 5 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 6 |
| Health Services | 3 |
Operativ
| Director/Board Member | 256 |
| Corporate Officer/Principal | 81 |
| Director of Finance/CFO | 46 |
| Independent Dir/Board Member | 43 |
| Private Equity Investor | 34 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| James Noble | 39 |
| Kapil Dhingra | 39 |
| Karen Wilson | 31 |
| Nanna Liebach Lüneborg | 29 |
| Peter Kiener | 25 |
| Stephen DiPalma | 24 |
| Guido Magni | 23 |
| Joël Jean-Mairet | 17 |
| Stephen Allen Hurly | 16 |
| Jay Backstrom | 15 |
| Edwin de Graaf | 14 |
| Erik van den Berg | 13 |
| Janke Dittmer | 13 |
| Fred M. Powell | 12 |
- Börse
- Insiders
- Stefan Luzi
- Unternehmensverbindungen
